| Kaiser Reef Limited (KAU) ORDINARY FULLY PAID |
Materials |
$139 |
FG1: Ore Purchase Agreement with Henty Gold Mine
|
6 Aug 2026 9:19AM |
$0.190 |
$0.230 |
risen by
21.05%
|
|
KAU - Price-sensitive ASX Announcement
Full Release
Key Points
- Flynn Gold Limited executed a non-binding Ore Purchase Agreement with Henty Gold Mine.
- The agreement provides a framework for Henty Gold Mine to purchase ore from Flynn Gold's Tasmanian projects.
- Flynn Gold aims to accelerate its Tasmanian project development, focusing on the Golden Ridge Project.
- The agreement is non-binding, with no obligation for either party to commit to a definitive transaction.
- Flynn Gold anticipates low-capex production pathways with the potential to reduce capital requirements.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| AIC Mines Limited (A1M) ORDINARY FULLY PAID |
Materials |
$616 |
Eloise Regional Exploration Update
|
6 Aug 2026 9:18AM |
$0.755 |
$0.770 |
risen by
1.99%
|
|
A1M - Price-sensitive ASX Announcement
Full Release
Key Points
- Drilling at Iris prospect shows extensive copper and gold mineralization.
- Significant intercepts at Iris include 1.8m grading 1.1% Cu and 0.2g/t Au.
- High-grade gold found at Eloise South with 3.2m grading 92.5g/t Au.
- Mineralization at Iris is similar to the Jericho copper deposit.
- Further drilling planned at Iris and Eloise South.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Djerriwarrh Investments Limited (DJW) ORDINARY FULLY PAID |
Financials |
$764 |
Appendix 3Y - Change of Director's Interest Notice
|
6 Aug 2026 9:17AM |
$2.910 |
$2.930 |
risen by
0.69%
|
|
| hipages Group Holdings Limited (HPG) ORDINARY FULLY PAID |
Communication Services |
$124 |
Notice of FY26 Results and Webinar
|
6 Aug 2026 9:16AM |
$0.735 |
$0.908 |
risen by
23.47%
|
|
| Regener8 Resources NL (R8R) ORDINARY FULLY PAID |
Materials |
$10 |
Regener8 to Divest Kookynie Gold Project to GA8
|
6 Aug 2026 9:15AM |
$0.125 |
$0.130 |
risen by
4%
|
|
R8R - Price-sensitive ASX Announcement
Full Release
Key Points
- Regener8 Resources NL (ASX: R8R) has agreed to sell its 100% interest in the Kookynie Gold Project to Goldarc Resources Limited (ASX:GA8).
- The sale includes prospecting licences P40/1506, P40/1513, P40/1515, P40/1516, P40/1517, P40/1518 and P40/1536.
- Total consideration for the sale is $2.5 million, comprised of $1.5 million in Goldarc shares and $1.0 million in contingent consideration.
- Contingent considerations are based on meeting specific milestones related to gold resource estimates within five years.
- Divestment allows R8R to focus on its Srebrenica North Project in Bosnia and Herzegovina.
- Phase 1 of soil sampling at Srebrenica North has been completed, covering the Zanik and Chaush prospects.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Goldarc Resources Limited (GA8) ORDINARY FULLY PAID |
Materials |
$39 |
GA8: Regener8 to Divest Kookynie Gold Project to GA8
|
6 Aug 2026 9:15AM |
$0.056 |
$0.055 |
fallen by
1.79%
|
|
GA8 - Price-sensitive ASX Announcement
Full Release
Key Points
- Regener8 Resources NL (ASX: R8R) has executed a binding sale and purchase agreement with Goldarc Resources Limited (ASX:GA8).
- The agreement involves the divestment of Regener8's 100% interest in the Kookynie Gold Project.
- Total consideration for the project is $2.5 million, comprised of $1.5 million in Goldarc shares and $1.0 million in contingent consideration.
- The contingent consideration is subject to Goldarc achieving specific Mineral Resource Estimates at the Kookynie Gold Project.
- The sale is subject to several conditions precedent, including shareholder and regulatory approvals.
- The divestment allows Regener8 to focus on its Srebrenica North Project in Bosnia and Herzegovina.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| iTech Minerals Ltd (ITM) ORDINARY FULLY PAID |
Materials |
$14 |
Outstanding Gold Intercepts at Reynolds Range
|
6 Aug 2026 9:15AM |
$0.036 |
$0.057 |
risen by
58.33%
|
|
ITM - Price-sensitive ASX Announcement
Full Release
Key Points
- Outstanding gold intercepts at Reynolds Range, NT.
- 36m at 5.6 g/t Au and 1.2% Sb at Sabre Prospect.
- Confirmation of steeply dipping zone of gold-antimony mineralisation.
- High-grade and thickness increase with depth.
- Drilling program includes six RC drill holes, results pending for two.
- Project covers 791km2 of the Aileron Province.
- Joint venture with SQM International Pty Ltd for lithium rights.
- Ongoing metallurgical tests for gold and antimony recovery.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Livium Ltd (LIT) ORDINARY FULLY PAID |
Industrials |
$15 |
Shareholder Webinar
|
6 Aug 2026 9:15AM |
$0.009 |
$0.007 |
fallen by
17.65%
|
|
| Argent Biopharma Limited (RGT) ORDINARY FULLY PAID |
Health Care |
$4 |
US Veterinary Development Programme for CannEpil Commences
|
6 Aug 2026 9:14AM |
$0.045 |
$0.033 |
fallen by
26.67%
|
|
RGT - Price-sensitive ASX Announcement
Full Release
Key Points
- Argent BioPharma Ltd announced the commencement of a U.S. veterinary development programme for CannEpil®.
- The programme is led by Splash Beverage Group and Lupvindol Biosciences.
- Dr. Hunter Land, former GW Pharmaceuticals executive, is leading the development team.
- The focus is on companion-animal oncology and chronic pain management.
- Development will proceed through the U.S. FDA Center for Veterinary Medicine.
- Argent BioPharma retains ownership of CannEpil® intellectual property.
- The programme is part of Argent BioPharma's strategy to expand CannEpil® into veterinary healthcare.
- The initiative aims to strengthen CannEpil®’s regulatory and commercial pathways in the U.S.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Marvel Gold Limited (MVL) ORDINARY FULLY PAID |
Materials |
$18 |
Marvel launches Investor Hub
|
6 Aug 2026 9:14AM |
$0.011 |
$0.013 |
risen by
18.18%
|
|
| Norwest Minerals Limited (NWM) ORDINARY FULLY PAID |
Materials |
$12 |
Results of Entitlement Offer
|
6 Aug 2026 9:12AM |
$0.006 |
$0.009 |
risen by
50%
|
|
NWM - Price-sensitive ASX Announcement
Full Release
Key Points
- Completion of a non-renounceable entitlement offer.
- Offer announced on 10 July 2026 and closed on 30 July 2026.
- Total amount raised: $1.89 million.
- Funds to be used for Bulgera Gold Project exploration and development.
- Entitlement offer was partly underwritten to $1.259 million.
- Participation from shareholders and underwriters was acknowledged.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Webjet Group Limited (WJL) ORDINARY FULLY PAID |
Consumer Discretionary |
$130 |
Update - Notification of buy-back - WJL
|
6 Aug 2026 9:12AM |
$0.395 |
$0.330 |
fallen by
16.46%
|
|
| Livium Ltd (LIT) ORDINARY FULLY PAID |
Industrials |
$15 |
Share Purchase Plan
|
6 Aug 2026 9:11AM |
$0.009 |
$0.007 |
fallen by
17.65%
|
|
| Pure Foods Tasmania Limited (PFT) ORDINARY FULLY PAID |
Consumer Staple |
$8 |
Release of Securities from Voluntary Escrow
|
6 Aug 2026 9:11AM |
$0.025 |
$0.023 |
fallen by
8%
|
|
| PDI Gold Limited (PDI) ORDINARY FULLY PAID |
Materials |
$4,604 |
General Meeting Webinar Invite
|
6 Aug 2026 9:10AM |
$0.710 |
$4.660 |
risen by
556.34%
|
|
| DigitalX Limited (DCC) ORDINARY FULLY PAID |
Information Technology |
$42 |
Update - Notification of buy-back - DCC
|
6 Aug 2026 9:10AM |
$0.026 |
$0.030 |
risen by
15.38%
|
|
| Breakthrough Minerals Limited (BTM) ORDINARY FULLY PAID |
Energy |
$25 |
High-Grade Copper-Gold Results Confirm Turpentine Extension
|
6 Aug 2026 9:10AM |
$0.170 |
$0.130 |
fallen by
23.53%
|
|
BTM - Price-sensitive ASX Announcement
Full Release
Key Points
- BTM confirmed high-grade copper-gold results at the Turpentine project.
- Extensive drilling was conducted across multiple sites.
- Results indicate a promising extension of mineralized zones.
- The Turpentine project enhances the North Queensland Copper-Gold Project's potential.
- Breakthrough Minerals Limited is positioned for future development based on these findings.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Viking Mines Limited (VKA) ORDINARY FULLY PAID |
Materials |
$25 |
LINKA STOCKPILES RETURN TUNGSTEN ASSAYS UP TO 1.8% WO3
|
6 Aug 2026 9:09AM |
$0.009 |
$0.010 |
risen by
11.11%
|
|
VKA - Price-sensitive ASX Announcement
Full Release
Key Points
- The Linka Project involves three historically producing tungsten mines: Linka, Conquest, and Hillside.
- Mineralisation occurs as scheelite-bearing skarn along the contact with granitic intrusive rocks.
- Recent trench sampling confirmed scheelite mineralisation along an 820m trend from Linka to Conquest.
- Stockpile sampling returned tungsten grades as high as 1.83% WO3.
- Metallurgical testwork produced a 56.9% WO3 concentrate at 76% recovery.
- TOMRA's ore sorting testwork is underway with assay results expected soon.
- Viking Mines aims to apply a sensor-based ore sorting technology.
- A systematic sampling program is planned to establish grades across dump areas.
- The Linka Project is positioned for a brownfields restart with existing infrastructure.
- The project aims for a tungsten supply that is free from Chinese sources due to US defense procurement restrictions.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Askari Metals Limited (AS2) ORDINARY FULLY PAID |
Materials |
$6 |
Company Secretary Appointment/Resignation
|
6 Aug 2026 9:09AM |
$0.007 |
$0.007 |
fallen by
0%
|
|
| wrkr Ltd (WRK) ORDINARY FULLY PAID |
Information Technology |
$143 |
Change of Director's Interest Notice - TL
|
6 Aug 2026 9:09AM |
$0.075 |
$0.066 |
fallen by
12%
|
|
| Pursuit Minerals Limited (PUR) ORDINARY FULLY PAID |
Materials |
$22 |
District-Scale System Confirmed at Sascha Marcelina
|
6 Aug 2026 9:09AM |
$0.068 |
$0.083 |
risen by
22.06%
|
|
PUR - Price-sensitive ASX Announcement
Full Release
Key Points
- Pursuit Minerals Limited's ASX ticker is PUR.
- District-scale mineral system confirmed at Sascha Marcelina.
- Significant exploration results include geophysical surveys and drilling.
- High-grade gold and silver intersections at Sascha Main target.
- Geophysical anomalies align with geological structures.
- Further exploration includes ground magnetic surveys and deep drilling.
- Applying a 1 g/t AuEq cut-off for intercept reporting.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Godolphin Resources Limited (GRL) ORDINARY FULLY PAID |
Materials |
- |
Building Value Through Gold, Silver & Copper Exploration
|
6 Aug 2026 9:05AM |
$0.020 |
$0.019 |
fallen by
5%
|
|
GRL - Price-sensitive ASX Announcement
Full Release
Key Points
- Godolphin Resources focuses on gold, silver, and copper exploration in NSW.
- The company is divesting non-core assets and spinning out the Narraburra REE Project.
- Lewis Ponds and Cousin Jack are key projects in the company's portfolio.
- The Gold-Copper Portfolio consists of eight exploration licenses covering 1,694 km².
- Strategic exploration includes Mt Aubrey and Copper Hill East Projects.
- Godolphin's total exploration licenses span 1,841 km², including several promising prospects.
- The company aims for long-term shareholder value through exploration success.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Switzer Dividend Growth Fund (Managed Fund) (SWTZ) |
Financials |
$53 |
Notional Derivatives Exposure - 31 July 2026
|
6 Aug 2026 9:04AM |
$2.470 |
$2.330 |
fallen by
5.67%
|
|
| Peako Limited (PKO) ORDINARY FULLY PAID |
Materials |
$33 |
Extensive gold systems discovered - KSA project rock samples
|
6 Aug 2026 9:03AM |
$0.006 |
$0.012 |
risen by
100%
|
|
PKO - Price-sensitive ASX Announcement
Full Release
Key Points
- Extensive sampling was conducted within the KSA project area.
- Notable gold mineralisation was discovered at various locations.
- Sample locations include Sukhaybarat South and Wadi Jarir.
- Peako Limited is actively exploring gold systems in Saudi Arabia.
- High gold values were found in several rock chip samples.
- Future exploration plans include drilling and further sampling.
- The exploration is supported by historical data and new findings.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Acrux Limited (ACR) ORDINARY FULLY PAID |
Health Care |
$7 |
Investor Presentation - Female Testosterone for HSDD
|
6 Aug 2026 9:02AM |
$0.011 |
$0.011 |
fallen by
0%
|
|
ACR - Price-sensitive ASX Announcement
Full Release
Key Points
- Acrux is developing a female testosterone therapy for HSDD using MDTS.
- Significant market potential for female-specific testosterone treatments.
- Clinical trials show increased satisfactory sexual events for users.
- Plans to expand therapy to other women's health issues.
- Seeking co-development partnerships for expedited product launch.
- History of innovation in drug delivery technologies.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
Call 1300 880 160
Start a chat
Schedule a call
